Connect with us


Australis Reports Q3 2021 Results

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF), today announced that the Company has filed its financials and management discussion and analysis for the third quarter of fiscal 2021, the period ending December 31, 2020. Condensed Interim Consolidated Statements of Financial Position (CNW Group/Australis Capital Inc.) Condensed Interim Consolidated Statements of Comprehensive Loss (CNW Group/Australis Capital […]

The post Australis Reports Q3 2021 Results appeared first on Technical420.

Republished by Plato



On November 17, 2020, an overwhelming majority of attending shareholders voted to support the new leadership team that was proposed by a group of concerned shareholders. Consequently, Dr. Duke Fu, Dr. Jason Dyck, Mr. Avi Geller, Mr. Hanoz Kapadia and Mr. John Esteireiro were elected as Directors of the Company. Dr. Duke Fu also was appointed as Interim CEO of the Company.

The period under review, Fiscal Q3 2021, relates to the period ended December 31, 2020. Results reported therefore relate predominantly to the legacy business and do not include any financials related to the proposed ALPS and Green Therapeutics LLC (“GT” or “Green Therapeutics”) acquisitions (see press releases dated January 5, 2021February 9, 2021 and February 24, 2021).

Events subsequent to the quarter

The new leadership team immediately commenced executing on the strategy put forward by the concerned shareholder group. In short order, predominantly subsequent to quarter’s end, a number of important changes and major achievements were reported:

Leadership changes

  • The Company appointed Jon Paul as its new CFO. Mr. Paul brings with him considerable public company experience in the cannabis industry, as well as a strong track record in driving profitability in very fast paced, emerging, regulated consumer industries.
  • In relation to the transaction whereby AUSA is proposing to acquire a majority interest in ALPS (see below), the Company announced that Mr. Terry Booth is to be appointed as CEO upon completion of the transaction. Mr. Booth is one of the visionaries and pioneers in the cannabis sector and has a strong track record in executing and driving shareholder value.
  • Upon the appointment of Mr. Booth as CEO, Dr. Duke Fu, currently Interim CEO, will take on the position of COO, with a special focus on driving organic growth and innovation. Dr. Fu, former President at MedMen Enterprises (2014-2015), also acts as the CEO of Green Therapeutics, an award-winning MSO headquartered in Nevada and has extensive experience in technology-driven GMP level manufacturing and science-based medical innovation.
  • The Company anticipates making further appointments to its leadership team as the Company progresses in its development.


  • The Company announced it would be acquiring a 51% interest, with an option for the remaining 49%, in ALPS, the world’s premier cultivation facility design, construction management, and (post) commissioning and compliance service provider for the cannabis and horticultural industries (see January 5, 2021 press release).
  • The Company and ALPS signed a definitive agreement (see February 24, 2021 press release) and expects to close the acquisition in early March.
  • As a global innovation leader in the horticultural and cannabis sectors, ALPS has signed multiple facility and service contracts in the past 6 weeks for total revenues in excess of $5 million, with the majority of the work to be completed in fiscal 2022. With a rapidly expanding business pipeline, the Company anticipates continued growth over the coming months.
  • With a number of existing customer relationships and significant contracts, ALPS brings significant revenues to the Company and is also anticipated to be immediately accretive to AUSA results following the closing of the acquisition.
  • 64% of the acquisition price is tied to significant revenue and EBITDA targets, reflecting the confidence of the ALPS management to profitably expand the business. Revenue targets range from $26.1 to $46.6 million over three annual periods. Corresponding EBITDA targets are $11.7 to $21.0 million.
  • ALPS is expected to enable the Company to fuel the scale-up of its brands across the U.S. and beyond without having to invest in CapEx heavy infrastructure, while retaining substantial margin. AUSA plans to leverage ALPS’s customer relationships, whereby customers, in return for ALPS developed IP, will grow AUSA’s portfolio of award-winning genetics, selling these back to AUSA at a reduced mark-up.


  • On January 5, 2021, the Company announced it has entered into a term sheet regarding the acquisition of Green Therapeutics LLC.
  • GT is an award-winning, Nevada-based cannabis company with a strong brand portfolio, comprised of GT Flowers, Tsunami and Provisions.
  • Led by former MedMen President Dr. Duke Fu, GT has assembled a strong team of medical professionals and pharmaceutical manufacturing experts. Based on the team’s experience and science-based approach, GT has created a portfolio of high-end dried flower and designer/luxury derivative products that are in high demand. GT products are carried by 52% of Nevada dispensaries.
  • With the proposed acquisition comes an 8,000 sqft cultivation and manufacturing facility, as well as Management and Brand Licensing Agreements with entities in Oklahoma and Missouri licensed for extraction and processing, and rights to acquire an interest in the Oklahoma entity and a 25% interest in the Missouri entity, both subject to regulatory approval.
  • The Company intends to leverage its ALPS driven expansion model, described above, to scale up the GT brands, providing consumers throughout the U.S. and beyond with access to GT’s in demand products.
  • The acquisition of GT is contingent on approval by the State of Nevada’s Cannabis Control Board and subsequent local approval by Clark County Department of Business License. The timing of Nevada Cannabis Compliance Board review and approval is beyond the control of the Company.

Q4 Outlook

The Company anticipates closing the ALPS transaction in early March and the GT transaction by the end of March. With less than a full month of integration, it is anticipated that ALPS will still bring a significant boost to revenues in Q4, with the full impact materializing in Q1. As the Company will not own 100% of GT until such time as the transfer of licenses is completed. The Company will not be able to consolidate plant touching revenues and will only consolidate revenues from non-plant touching ancillary services resulting in receipt by AUSA of management fees, equipment leasing, and IP licensing fees. Of further note:

  • The new leadership team has reduced personnel costs to conserve cash during Q4 as well as dramatically lowered legal and investor relation fees after the proxy fight.
  • The sale of the North Las Vegas land is expected to bring $1.9 million cash for the Company’s share when the closing is completed (anticipated to occur by the end of March).
  • The value of the Company’s investment in Body and Mind Inc. (“BAMM”) has increased by $5.5 million since year-end and is anticipated to make a positive contribution in Q4. Shares of BAMM as at March 1, 2021 closed at $0.79, as compared to $0.49 as at December 31, 2020.
  • Quality Green Inc., an Ontario based private cannabis company in which the Company holds an investment, is in the middle of completing a private placement of securities. Based on the valuation expected by Quality Green’s top management, the value of the Company’s stake will increase by $1.5 million.

Management Commentary

Dr. Duke Fu, Interim CEO, commented, “We are delivering on the promises made to our shareholders when the new leadership team took over. We are executing at a very high pace, with two proposed acquisitions announced and moving towards completion, a completely new leadership team installed, ALPS firing on all cylinders with over $5 million in contracts signed in the past six weeks, and the team is progressing on further potential partnerships, transactions and strategic revenue enhancing initiatives. Consequently, we are exceptionally well positioned to leverage our assets and execute on our unique expansion strategy to transform AUSA into a meaningful, national MSO.”

Jon Paul, CFO, added, “The Company’s third quarter results were impacted by a number of non-cash impairment charges against legacy assets and operations, as well as one off charges related to the recent proxy battle and the resulting reorganization of the Company’s board and management. Without these extraordinary expenses, net loss would have been limited to $2.3 million. The cash burn from operations during the quarter of $2.7 million was consistent with the first half of fiscal 2021. As we wrap up the restructuring of the legacy operations, we have a cleaner slate for focusing on the ALPS, GT and other potential acquisitions and partnerships as we scale our business.”

Mr. Paul added, “Going forward into fiscal Q4, we anticipate a number of material events to boost our results. We expect to close on the ALPS transaction in early March, which is anticipated to bring a significant boost to revenues, even with less than one month left in the quarter. The full revenue impact from ALPS will be felt the following quarter, Q1 of fiscal 2022. Our investments in BAMM and Quality Green, as of today, are up by approximately $7.0 million. The sale of land held in North Las Vegas is expected to bring approximately $1.9 million cash when the land sale closes at the end of March.”

Q3 2021 Overview

The financial results for Q3 2021 concern the period ended December 31, 2020. These results therefore reflect the legacy business only, with minimal technology and consulting revenue, and do not properly reflect the operations of the Company going forward.

The results for the period under review were impacted by a number of one-off, mostly non-cash extraordinary items. A net loss of $19.4 million was recorded, versus $5.8 million for the prior year’s comparable quarter. The increased loss was due predominantly to extraordinary items, which totaled $17.6 million. Adjusted for these items, the Company would have recorded a $1.8 million operating loss, a $4.0 million improvement over the prior year’s quarter.

The list below provides an overview of the aforementioned extraordinary items:

1. The Company, has decided to record a number of non-cash impairments of intangibles related to the legacy business the new leadership team inherited upon taking charge at AUSA:

    • $5.3 million impairment of the Passport license.
    • $2.4 million impairments of the Rthm goodwill and software.

2. Other non-cash adjustments recorded

    • $2.3 million in reductions in the carrying value of land held for sale in Washington state and North Las Vegas.
    • $1.2 million in reductions in the value of marketable securities in Folium Equity Holding, LLC and BAMM (the latter driven by a change in accounting method away from an investment valuation)

3.  Reorganization

    • $3.4 million in costs related to the proxy battle and board/management changes, consisting primarily of additional legal fees and investor relations costs and to a lesser extent, estimated net costs of settling compensation and equity matters with the prior board and management.
    • $3.0 million in a settlement and restructuring provision to address legal, restructuring, and other settlement obligations and costs which arose from events during the quarter, in particular, costs incurred with the GT legal settlement and revised term sheet.

Q3 Financial overview

1.  Revenues and Gross Margins

    • Revenues were minimal at $90K, consisting of consulting fees from BAMM and technology revenue from Cocoon. Gross margins were negative $(166K) due to the costs of supporting the Company’s Cocoon line in its early stages.

2.  Operating Expenses

    • Operating expenses came in at $4.9 million, as compared to $3.2 million for the same period in the prior year but included $3.4 million in one-time costs mentioned above related to the proxy battle. Otherwise, costs would have been under half of the costs in Q3 FY 2020.

3.  Loss from Operations

    • $5.1 million operational loss was recorded, an increase of $2.0 million, driven primarily by one-off costs related to the aforementioned restructuring and proxy activities. Adjusted for these extraordinary costs, the net quarterly loss would have been $1.7 million, an improvement over the prior quarter by $0.8 million.

4.  Net Loss

    • $19.4 million net loss was recorded vs. a loss of $5.8 million in Q3 of the prior year. Without $17.6 million in one-off costs and impairments, the loss would have been $1.8 million.

Working Capital & Liquidity

As at December 31, 2021, the Company held $7.6 million in cash, as well as $9.9 million in marketable securities. Working capital stood at $7.0 million, a decrease by $12.8 million over the prior year, due primarily to a decrease in cash of $8.7 million, with no cash raised during the first nine months of FY 2021, along with $1.2 million spent on construction in progress on the North Las Vegas land, which has now been reclassified for sale and $3.0 million in accrued provision liabilities for reorganization costs mentioned above.

Cash flow during the quarter was comprised of the following:

  1. Cash used in Operations during Q3 2021 was $2.7 million, in line with the prior quarter.
  2. Cash used for investments during the quarter was $0.4 million in construction in progress on the land held for sale, which the company anticipates closing in Q4.
  3. Financing costs of $0.2 million were recorded, related to leases and share-based compensation.
  4. A Foreign Exchange gain of $0.5 million was recorded.

The Company’s financial statements and management discussion & analysis were filed on SEDAR and can be found on

Conference call details

Management will host a conference call discussing the results and the go forward business on March 2, 2021 at10AM EST. The call can be accessed via telephone or via webcast per the details provided below.



North American Toll Free:


Webcast URL:

Confirmation #:


A replay of the call will be available until March 9, 2021. The replay can be accessed as follows:

Encore Replay Canada:


Encore Replay North American Toll Free:


Encore Replay Entry Code:


About AUSA

AUSA is implementing a growth strategy towards establishing a highly competitive and profitable MSO in the U.S. and global cannabis markets. AUSA is in the process of closing a transaction to acquire 51% ownership of ALPS, the world’s premier design, construction management, commissioning and post commissioning consultancy for horticultural crops, such as cannabis, fruits, vegetables, mushrooms and algae. The Company will also hold an option for the acquisition of the remaining 49% of ALPS. AUSA is currently working towards the closing of a transaction whereby it will acquire 100% of the membership interest in Green Therapeutics LLC, an award-winning MSO with operations in NevadaMissouri and Oklahoma. Through GT and ALPS, the Company believes it will be able to secure low-cost access to cannabis biomass to fuel the scale up of its award-winning brands across the U.S. and global cannabis markets. AUSA’s other business and assets include investments in Cocoon, Body and Mind Inc., Quality Green, Folium Biosciences, and land assets in Washington and Michigan.

The Company’s common shares trade on the CSE under the symbol “AUSA” and on the OTCQB under the symbol “AUSAF”.

Forward-Looking Statement

This press release contains “forward-looking information” within the meaning of applicable securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. Generally, forward-looking information may be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. In particular, this press release contains forward-looking information in relation to: the timing and ability to close the proposed transactions with GT and ALPS; the anticipated development of the GT and ALPS businesses and their impact on the Company; the ability of the Company to execute on its strategy to establish a low capex model MSO; the proposed management changes; the outlook for the fourth quarter; the impact of the changes to U.S. federal and state developments with respect to the cannabis industry and the opportunities this may present for the Company. This forward-looking information reflects the Company’s current beliefs and is based on information currently available to the Company and on assumptions the Company believes are reasonable. These assumptions include, but are not limited to: the ability of the Company to successfully satisfy the conditions to closing the ALPS and GT transactions; the ability of management of ALPS, GT and the Company to successfully execute on their respective business plans; legal changes relating to the cannabis industry proceeding as anticipated; and the Company’s continued response and ability to navigate the COVID-19 pandemic being consistent with, or better than, its ability and response to date.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; the actual results of the Company’s future operations; competition; changes in legislation affecting the Company; the timing and availability of external financing on acceptable terms; lack of qualified, skilled labour or loss of key individuals; risks related to the COVID-19 pandemic.

EBITDA is a Non-IFRS measure. Earnings before interest, taxes, depreciation and amortization (“EBITDA”) should not be construed as alternatives to net income/loss determined in accordance with IFRS. EBITDA does not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. The Company believes that EBITDA is a meaningful financial metric as it measures cash generated from operations, which the Company can use to fund working capital requirements and fund future growth initiatives.

A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents on the SEDAR website at Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking information contained in this press release is expressly qualified by this cautionary statement. The forward-looking information contained in this press release represents the expectations of the Company as of the date of this press release and, accordingly, are subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.

Notes to the financial statements can be found in the financial statements filed on SEDAR under the Company’s profile (

SOURCE Australis Capital Inc.

Related Links

Checkout PrimeXBT
Trade with the Official CFD Partners of AC Milan


Berry Streusel Bars With Weed

Berry Streusel Bars With Weed There’s nothing better than healthy, wholesome weed recipes and today we’re making Berry Streusel Bars With Weed. Layered with fresh fruit, oats, cannabis oil, almond butter and applesauce – not only are these a welcome treat when you feel like an edible, they’re also pretty healthy! What is Streusel? From […]

The post Berry Streusel Bars With Weed appeared first on .

Republished by Plato



Berry Streusel Bars With Weed

There’s nothing better than healthy, wholesome weed recipes and today we’re making Berry Streusel Bars With Weed.

Layered with fresh fruit, oats, cannabis oil, almond butter and applesauce – not only are these a welcome treat when you feel like an edible, they’re also pretty healthy!

What is Streusel?

From what we know and understand, streusel originated in Germany.

Streusel, pronounced: Strew-sell translated to it’s simpliest form means sprinkles.

So streusel is a sprinkling of a mixture of delicious crumbly ingredients that sit beautifully at the top of a bar or cake.

The top layer is crunchy-crumbly, and the inside layer is gooey and decadent!

How Do I Make Edibles?

Edibles, when following our recipes correctly, can be the nicest and tastiest way to enjoy cannabis.

You’ll always want to be careful because if you’re new to the weed-world, edibles take longer to kick in, so don’t chow down quickly hoping for fast results.

When eating edibles, use the Marijuana Mantra:

picture of a cannabis leaf for edible marijuana

“Dose LOW and Dose SLOW!”

— The Marijuana Mantra

You can use and create a variety of staples when it comes to baking or cooking with cannabis.

Cannabis butter, for example, can be used in cookies, cakes, stir-fries and hearty lunch and dinner dishes.

Cannabis oil can be used in salads, baking, and as a tasty drizzle on veggies.

And of course, you can create Cannabis sugar which is a welcome addition to a hot cup of tea, coffee, or any baking where you want to infuse weed into the recipe.

What Does This Recipe Require?

First, we’ll make our cannabis oil. Using the step-by-step recipe below, you’ll need ot decarb your weed first.

Once that’s done, making oil is relatively easy!

Ingredients For Berry Streusel Bars With Weed

With it’s crumbly-top texture, and soft-sweet centre, you’ll love this bars loaded with flavour and cannabis.

The best thing to do is when you’re finished and the bars have cooled, cut them up into squares, and pop them into the freezer with proper labels so you can pull them out any time of day!

You’ll need:

  • fresh mixed berries
  • cornstarch
  • pure maple syrup
  • coconut sugar or brown sugar
  • gluten free oats
  • cinnamon
  • almond butter
  • applesauce
  • cannabis oil

Berry Filling: it’s like a thick, juicy jam and holds everything together!

Streusel: crunchy and crumbly, it’s literally the icing on the cake!

Notice we aren’t using eggs or flour? This is great for anyone on a restrictive diet too!


Baking Tips

This is a super yummy recipe, but it does take time. Set aside the space and appropriate time that it takes so you won’t be disappointed!

Having a dedicated space where you can cool the bars, while making sure little one’s don’t touch (if you have children) is super important.

You can always sub in granulated white sugar, or Swerve Sugar too.

Doubling up on this batch means a little more work, but a bigger yield and more options for edible snacks in the future!

Enjoy & happy Canna-Baking!

The Recipe


Crumbly-Crunchy goodness on top, with weed infused gooey-berry filling in the centre!

0 from 0 votes

Prep Time: 1 hour

Cook Time: 30 minutes

Cooling Time: 2 hours

Course: Dessert

Keyword: cannabis desserts, cannabis oil, streusel

Servings: 4 people

Author: Steph Van De Ven

Cost: 25+

  • Large Bowl

  • measuring cups & spoons

  • Whisk

  • Spatula

  • Saucepan

  • 8 inch square pan

  • Parchment Paper

  • Food Processor

Berry Filling

  • 1 1/2 tbsp cornstarch
  • 2 cups fresh or frozen berries do not thaw the frozen berries if you decide to use this option
  • 1 1/2 tbsp water
  • 1/4 cup pure maple syrup
  • 1 tbsp sugar coconut sugar, brown or granulated. You can also use Swerve.

Streusel & Crust

  • 2 1/2 cups old fashioned, gluten-free rolled oats
  • 1/2 tsp ground cinnamon
  • 1 cup almond butter
  • 1/4 cup pure maple syrup
  • 1/2 cup applesauce unsweetened
  • 1/4 cup Cannabis Coconut Oil
  • 1/2 cup Chopped almonds save until the end
  • Berry Filling: Whisk the cornstarch and water together until all the cornstarch has dissolved. Make sure you use cold water, not hot. Put the cornstarch mixture, berries, maple syrup, and sugar of choice in a medium saucepan over medium heat. Using a rubber spatula, stir the mixture as it cooks. Stir constantly.After 2 minutes, remove pan from the heat and allow to cool completely. Don’t worry! The mixture will thicken as it cools.
  • Next, preheat oven to 350°F. Line the bottom and sides of an 8-inch or 9-inch square baking pan with parchment paper.
  • Next, we’ll make the crust/streusel: Pulse the oats in a food processor or blender until they’re slightly broken up. Pour into a bowl and stir in the cinnamon, almond butter, maple syrup, applesauce, and cannabis coconut oil. Mixture will be thick and wet – exactly what you want!
  • Put the mixture into the prepare pan, using the spatula flatten it down. Make sure it’s flat and very compact, which helps guarantee the bars will hold their shape. Then, you can spread cooled berry filling evenly on top.
  • For Your Topping: Mix the sliced almonds into the remaining crust/streusel mixture. Sprinkle all over the top of the berry filling. Sprinkle oats evenly on top. (Helps soak up some moisture.)

  • Bake for 27-31 minutes or until the topping is lightly browned. Remove from the oven and place baking pan on a cooling rack. Allow bars to cool completely. Cut into squares.

If you’re looking to up-level your canna-cooking game, you may want to start here.

For more recipes like this one, check out our recipe index here.

Share our post and comment below! We’d love to hear from you.

As always, happy canna-cooking!

Invest w Mintos

Continue Reading


Namaste Technologies Provides a Corporate Update

Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) a marketplace platform for cannabis and wellness products, is pleased to provide the following corporate updates. Namaste is pleased to announce that its wholly-owned subsidiary, CannMart Inc. (“CannMart”) has expanded its product offering to both our provincial customers who sell to recreational consumers and to our own […]

The post Namaste Technologies Provides a Corporate Update appeared first on Technical420.

Republished by Plato



Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) a marketplace platform for cannabis and wellness products, is pleased to provide the following corporate updates.

Namaste is pleased to announce that its wholly-owned subsidiary, CannMart Inc. (“CannMart”) has expanded its product offering to both our provincial customers who sell to recreational consumers and to our own medical customers across Canada at, by entering into a number of supply agreements including with CannTx Life Sciences Inc., Rilaxe Canna Inc. and Safari Flower Co.

CannTx Life Sciences Inc.:

A supply agreement with CannTx Life Sciences, a licensed cultivator and processor, to distribute Royal City Cannabis Co. branded premium artisanal hash products. These high purity handcrafted pressed ice hash products are derived from single strain whole flower cannabis material and washed in small batches to ensure the highest quality hash for Royal City’s consumers. These products will be sold and distributed throughout CannMart’s provincial footprint starting in Ontario in the adult use market and online through the medical platform via

Rilaxe Canna Inc.:

A Canada-wide exclusive production and distribution agreement with Rilaxe Canna bringing to market a new format of edibles that are made from dried fruit with the intention to serve the wellness community, medical patients and adult use customers. There are presently only gummies and chocolate available in the edibles category across the country and this new novel line of products will further expand the category. CannMart is in a unique position to take a first mover advantage with this exciting new product offering. These products will be sold and distributed throughout CannMart’s provincial footprint starting in British Columbia in the adult use market and online through the medical platform via

Safari Flower Co.:

A supply agreement with Safari Flower, a licensed cultivator and processor for various flower and various cannabis 2.0 categories. CannMart will be distributing products through its provincial body supply agreements and online through the medical platform via

“We are very pleased to welcome all our new partners including, CannTx Life Sciences, Rilaxe Canna and Safari Flower to CannMart as we continue to expand our product offering to our customers,” said Meni Morim, CEO of Namaste. “We are excited to have these products available by the end of May of this year as we look to grow our future revenues. These products will be available for our medical patients across Canada online at, and through our business-to-business distribution channels throughout our provincial customers. The team continues to work very hard at successfully bringing in new partners as we look to be the world’s foremost marketplace in wellness.”

About CannTx Life Sciences Inc.

CannTx Life Sciences is a privately-owned cannabis producer licensed by Health Canada under the Cannabis Act. As a producer of consumer cannabis products, CannTx is uniquely equipped to provide Plant Tissue Culture services alongside horticultural solutions to fellow Licensed Producers under its B2B division, Steadystem Solutions. From pathogens remediation and in-vitro storage (SteadyStorage) to scheduled provision of clean donor stock (SteadyStock) to production ready inputs (SteadyStarts) Steadystem can help operators reach their full potential. This biotech platform supports CannTx’s consumer cannabis product divisions, Bower Therapy (Medicinal) and Royal City Cannabis Co. (Recreational) and serve as the foundation of quality and consistency of their products. Steadystem Solutions continues to grow its library of validated genetics characterized across a holistic assessment of important agronomic traits. The company was incorporated in 2013 and is located near Guelph, Ontario, in the heart of Canadian agricultural innovation.

About Rilaxe Canna:

Rilaxe Canna is a privately-owned company located in Vancouver, British Columbia producing edibles with high-quality THC distillate that’s sourced locally from our fellow extractionists. Our delicious line of dried fruits are sourced sustainability from local suppliers here in BC. Made only with ingredients that are natural and 100% free of synthetic preservatives that may be harmful to our bodies. Our fruits are certified organic and vegan friendly. Our fruit suppliers focus on social, environmental and economic responsibilities and ethically source their dried fruits from farms across the world who are using approved organic farming methods to support local communities.

About Safari Flower Co.

Safari Flower is a privately-owned company located in Fort Erie, Ontario which cultivates new wave cannabis flowers of unique character for today’s generation of sophisticated consumers. Safari strives to bloom the best out of the plant’s native potential to maximize each cultivar’s most wild and natural expression. Buds are slowly harvested and trimmed by hands in small-batch rooms to preserve the distinct character of every flower; from visual texture to complex aromas and flavours that makes for extraordinary products.

About Namaste Technologies Inc.

Headquartered in Toronto, Canada, Namaste Technologies is a marketplace platform for cannabis and wellness products. At, the Company provides Canadian medical customers with a diverse selection of hand-picked products from a multitude of federally licensed cultivators and US customers with access to hemp-derived CBD and smoking accessories. The Company also distributes licensed and in-house branded cannabis and cannabis derived products in Canada through a number of provincial government control boards and retailing bodies and facilitates licensed cannabis retailer sales online in Saskatchewan. Namaste’s global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions.

Information on the Company and its many products can be accessed through the links below:

For more information please contact:
Namaste Technologies Inc.
Meni Morim, CEO
Edward Miller, VP Investor Relations
Ph: 647-362-0390

Source: Namaste Technologies Inc

FORWARD-LOOKING INFORMATION – This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen.

The forward-looking information contained herein, including, without limitation, statements related to distribution of products on and through CannMart provincial buyers are made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made, including, without limitation, Namaste’s ability to maintain momentum of expanding the CannMart Inc. business, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: regulatory risk, risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom and risks specifically related to the Company’s operations. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Share Share - Facebook Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Coinsmart. Beste Bitcoin-Börse in Europa

Continue Reading


Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) is pleased to announce the launch of its trailblazing new cannabis wellness brand Noon & Night. It launches with two new innovative product formats, the first of its kind Omega CBD Soft Gels and Lavender Fizz CBD bath bombs, both of which are now available in the adult-use […]

The post Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels appeared first on Technical420.

Republished by Plato



“Noon & Night is highly differentiated, filling a clear gap in the cannabis brand landscape with its exclusive focus on health and wellness conscious consumers,” said Aleafia Health CEO Geoffrey Benic. “This forms an important part of our concerted entrance into the Canadian adult-use market, perfectly complementing our recently launched edibles brand Bogart’s Kitchen and everyday cannabis brand Divvy. The consistent theme in the rapid expansion of our product portfolio is through leaning on our core competitive advantages.”

The Omega CBD Soft Gels feature full-spectrum, single strain CBD extract, and are the first Canadian cannabis products to be suspended in fish oil containing omega-3. Omega-3s are an essential fatty acid, and one of the most popular nutritional supplements in North America. Additionally, many patients and consumers prefer soft gels as they are easier to swallow, relative to dissolvable capsules. Each soft gel contains 30 mg of CBD, with 30 soft gels per bottle.

The Lavender Fizz CBD bath bombs are handcrafted and locally produced at the Company’s Paris, Ont. product innovation centre. Made with locally sourced lavender flower, they contain no artificial dyes or colours, and each contain 100 mg of CBD. They also boast the most accessible price point in their product category in the adult-use market.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Coinsmart. Beste Bitcoin-Börse in Europa

Continue Reading


A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America